Terms: = Germ cell tumor AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1
821 results:
1. vegfr2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis.
Guo M; Zhang J; Han J; Hu Y; Ni H; Yuan J; Sun Y; Liu M; Gao L; Liao W; Ma C; Liu Y; Li S; Li N
J Transl Med; 2024 May; 22(1):419. PubMed ID: 38702818
[TBL] [Abstract] [Full Text] [Related]
2. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
Ichimura N; Urata Y; Kobayashi T; Hibi H
Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell sequencing reveals vegfr as a potential target for CAR-T cell therapy in chordoma.
Wu H; Li X; Zhang B; Liu P; Qi M; Du Y; Zhang C; Duan W; Chen Z
Br J Cancer; 2024 Jun; 130(10):1609-1620. PubMed ID: 38605247
[TBL] [Abstract] [Full Text] [Related]
4. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
5. Grafted Sertoli cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer.
Chiappalupi S; Salvadori L; Borghi M; Mancuso F; Pariano M; Riuzzi F; Luca G; Romani L; Arato I; Sorci G
Cells; 2024 Mar; 13(6):. PubMed ID: 38534388
[TBL] [Abstract] [Full Text] [Related]
6. VEGF/vegfr axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
7. [Systemic treatment of adult gliomas: a narrative review].
Mangel L
Magy Onkol; 2024 Mar; 68(1):67-75. PubMed ID: 38484377
[TBL] [Abstract] [Full Text] [Related]
8. BAP31 Promotes Angiogenesis via Galectin-3 Upregulation in Neuroblastoma.
Namusamba M; Wu Y; Yang J; Zhang Q; Wang C; Wang T; Wang B
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474195
[TBL] [Abstract] [Full Text] [Related]
9. Changes in the Concentrations of Proangiogenic Cytokines in Human Brain Glioma and Acute Lymphoblastic Leukemia.
Oldak L; Zielinska Z; Milewska P; Chludzinska-Kasperuk S; Latoch E; Konończuk K; Krawczuk-Rybak M; Starosz A; Grubczak K; Reszeć J; Gorodkiewicz E
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473833
[TBL] [Abstract] [Full Text] [Related]
10. Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study.
Lu F; Wu Q; Lei J; Zhou Y; Liu Y; Zhu N; Yu Y; Lin L; Hu M
Arch Biochem Biophys; 2024 Apr; 754():109957. PubMed ID: 38467357
[TBL] [Abstract] [Full Text] [Related]
11. Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool.
Zhang Q; Yang Z; Zhang J; Li Y; Dang X; Qu J; Pan X; Zhang J
Bioorg Chem; 2024 Apr; 145():107240. PubMed ID: 38412651
[TBL] [Abstract] [Full Text] [Related]
12. Decoding the synergistic potential of MAZ-51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals.
Letsoalo K; Nortje E; Patrick S; Nyakudya T; Hlophe Y
Cell Biochem Funct; 2024 Mar; 42(2):e3950. PubMed ID: 38348768
[TBL] [Abstract] [Full Text] [Related]
13. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over vegfr/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
[No Abstract] [Full Text] [Related]
14. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
Zhao S; Zhang M; Zhang Q; Wu J; Dai H
BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
[TBL] [Abstract] [Full Text] [Related]
15. Exosome-transmitted ANGPTL1 suppresses angiogenesis in glioblastoma by inhibiting the VEGFA/vegfr2/Akt/eNOS pathway.
Wang D; Li H; Zeng T; Chen Q; Huang W; Huang Y; Liao Y; Jiang Q
J Neuroimmunol; 2024 Feb; 387():578266. PubMed ID: 38150891
[TBL] [Abstract] [Full Text] [Related]
16. Neovascularization directed by CAVIN1/CCBE1/VEGFC confers TMZ-resistance in glioblastoma.
Wang M; Xia D; Xu D; Yin Y; Xu F; Zhang B; Li K; Yang Z; Zou J
Cancer Lett; 2024 Feb; 582():216593. PubMed ID: 38092144
[TBL] [Abstract] [Full Text] [Related]
17. In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma.
Senrung A; Tripathi T; Yadav J; Janjua D; Chaudhary A; Chhokar A; Aggarwal N; Joshi U; Goswami N; Bharti AC
BMC Cancer; 2023 Nov; 23(1):1173. PubMed ID: 38036978
[TBL] [Abstract] [Full Text] [Related]
18. m5C modification of LINC00324 promotes angiogenesis in glioma through CBX3/vegfr2 pathway.
Pan A; Xue Y; Ruan X; Dong W; Wang D; Liu Y; Liu L; Lin Y; E T; Lin H; Xu H; Liu X; Wang P
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128409. PubMed ID: 38016610
[TBL] [Abstract] [Full Text] [Related]
19. Dual targeting of DR5 and vegfr2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesis.
Isakova AA; Artykov AA; Plotnikova EA; Trunova GV; Khokhlova VА; Pankratov AA; Shuvalova ML; Mazur DV; Antipova NV; Shakhparonov MI; Dolgikh DA; Kirpichnikov MP; Gasparian ME; Yagolovich AV
Int J Biol Macromol; 2024 Jan; 255():128096. PubMed ID: 37972835
[TBL] [Abstract] [Full Text] [Related]
20. STING activation counters glioblastoma by vascular alteration and immune surveillance.
Joseph JV; Blaavand MS; Cai H; Vernejoul F; Knopper RW; Lindhardt TB; Skipper KA; Axelgaard E; Reinert L; Mikkelsen JG; Borghammer P; Degn SE; Perouzel E; Hager H; Hansen B; Kalucka JM; Vendelbo M; Paludan SR; Thomsen MK
Cancer Lett; 2023 Nov; 579():216480. PubMed ID: 37931834
[TBL] [Abstract] [Full Text] [Related]
[Next]